Review Maps Aging Hallmarks onto Vascular Decline
This article discusses an open-access review that examines vascular aging through the framework of the hallmarks of aging. It notes that vascular dysfunction is a major cause of mortality, including atherosclerosis, leaky vessels, capillary rarefaction, and impaired smooth muscle function. The review highlights senescent cells and senotherapeutics as the most developed area for potential treatment, while regulatory and clinical trial hurdles remain.
The reviewed work organizes age-related vascular changes around the hallmarks of aging. It describes how the arterial wall’s three layers—intima, media, and adventitia—lose coordinated function as endothelial cells, smooth muscle cells, and pericytes shift behavior. Endothelial progenitor reserves decline, and extracellular matrix remodeling turns the vascular niche toward inflammation and structural deterioration.
Among possible interventions, senescent-cell research is furthest along. Senotherapeutics have preclinical support, yet regulatory acceptance and lengthy, costly trials remain barriers. Some early candidates are inexpensive, but the article notes they may stay unused until regulators and clinicians engage more fully.
If vascular aging therapies advance, older adults at risk of atherosclerosis, stroke, and heart attack could benefit most. Clinicians and regulators may face pressure to evaluate senotherapeutics, including low-cost options, through large trials. Health systems might see delayed or uneven access, depending on evidence and approval. The broader public could gain from better understanding that arterial decline shapes many age-related conditions, though benefits may take years to reach routine care.